{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:55:26Z","timestamp":1790621726269,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":433,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1038\/mt.2015.58","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T11:42:25Z","timestamp":1428666145000},"page":"1368-1379","source":"Crossref","is-referenced-by-count":83,"title":["High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa"],"prefix":"10.1016","volume":"23","author":[{"given":"Tobias","family":"K\u00fchl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Mezger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Hausser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Handgretinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Bruckner-Tuderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2015.58_bib1","series-title":"2013 Report on the State of the Art of Rare Disease Activities in Europe","author":"Aym\u00e9","year":"2013"},{"key":"10.1038\/mt.2015.58_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymgme.2008.10.003","article-title":"Clinical research for rare disease: opportunities, challenges, and solutions","volume":"96","author":"Griggs","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2015.58_bib3","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/mt.2015.58_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev-genom-090413-025540","article-title":"The genetics of skin fragility","volume":"15","author":"Has","year":"2014","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1038\/mt.2015.58_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00441-009-0866-y","article-title":"Basement membranes and human disease","volume":"339","author":"Van Agtmael","year":"2010","journal-title":"Cell Tissue Res"},{"key":"10.1038\/mt.2015.58_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399406000123","article-title":"Molecular basis of inherited skin-blistering disorders, and therapeutic implications","volume":"8","author":"Aumailley","year":"2006","journal-title":"Expert Rev Mol Med"},{"key":"10.1038\/mt.2015.58_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.det.2009.10.011","article-title":"Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa","volume":"28","author":"Chung","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1038\/mt.2015.58_bib8","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/humu.21651","article-title":"The COL7A1 mutation database","volume":"33","author":"Wertheim-Tysarowska","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1038\/mt.2015.58_bib9","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/humu.21551","article-title":"The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations","volume":"32","author":"van den Akker","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1038\/mt.2015.58_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ajmg.c.30035","article-title":"Progress in epidermolysis bullosa: genetic classification and clinical implications","volume":"131C","author":"Uitto","year":"2004","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1038\/mt.2015.58_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-5-12","article-title":"Inherited epidermolysis bullosa","volume":"5","author":"Fine","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1038\/mt.2015.58_bib12","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1038\/jid.2013.127","article-title":"Progress in Epidermolysis bullosa research: summary of DEBRA International Research Conference 2012","volume":"133","author":"Bruckner-Tuderman","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2015.58_bib13","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/mt.2014.169","article-title":"Small-molecule therapies for genetic skin fragility","volume":"22","author":"Bruckner-Tuderman","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.58_bib14","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1038\/mt.2014.140","article-title":"Aminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa","volume":"22","author":"Cogan","year":"2014","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.58_bib15","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jaad.2013.08.014","article-title":"A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa","volume":"69","author":"Venugopal","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/mt.2015.58_bib16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/bjd.12599","article-title":"Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial","volume":"169","author":"Petrof","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1038\/mt.2015.58_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone marrow transplantation for recessive dystrophic epidermolysis bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2015.58_bib18","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/exd.12084","article-title":"One goal, different strategies\u2013molecular and cellular approaches for the treatment of inherited skin fragility disorders","volume":"22","author":"H\u00fcnefeld","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1038\/mt.2015.58_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","article-title":"Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa","volume":"12","author":"Conget","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1038\/mt.2015.58_bib20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1038\/mt.2015.58_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","article-title":"Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production","volume":"15","author":"N\u00e9meth","year":"2009","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.58_bib22","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1634\/stemcells.2007-0226","article-title":"Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis","volume":"25","author":"Wu","year":"2007","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2015.58_bib23","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.4049\/jimmunol.180.4.2581","article-title":"Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type","volume":"180","author":"Sasaki","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/mt.2015.58_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1038\/mt.2015.58_bib25","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2015.58_bib26","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.58_bib27","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3324\/haematol.13699","article-title":"Mesenchymal stem cells: the fibroblasts\u2019 new clothes?","volume":"94","author":"Haniffa","year":"2009","journal-title":"Haematologica"},{"key":"10.1038\/mt.2015.58_bib28","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1172\/JCI68127","article-title":"Collagen VII plays a dual role in wound healing","volume":"123","author":"Nystr\u00f6m","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2015.58_bib29","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/jid.2013.328","article-title":"TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds","volume":"134","author":"Qi","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2015.58_bib30","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/01.RES.0000225952.61196.39","article-title":"Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling","volume":"98","author":"Uemura","year":"2006","journal-title":"Circ Res"},{"key":"10.1038\/mt.2015.58_bib31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5966\/sctm.2011-0018","article-title":"Concise review: role of mesenchymal stem cells in wound repair","volume":"1","author":"Maxson","year":"2012","journal-title":"Stem Cells Transl Med"},{"key":"10.1038\/mt.2015.58_bib32","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/wound.2013.0449","article-title":"Stem Cells and Healing: Impact on Inflammation","volume":"2","author":"Ennis","year":"2013","journal-title":"Adv Wound Care (New Rochelle)"},{"issue":"5 Pt 1","key":"10.1038\/mt.2015.58_bib33","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1083\/jcb.111.5.2109","article-title":"Epithelial origin of cutaneous anchoring fibrils","volume":"111","author":"Regauer","year":"1990","journal-title":"J Cell Biol"},{"key":"10.1038\/mt.2015.58_bib34","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/1523-1747.ep12265460","article-title":"Evaluation of anchoring fibrils and other components of the dermal-epidermal junction in dystrophic epidermolysis bullosa by a quantitative ultrastructural technique","volume":"84","author":"Tidman","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2015.58_bib35","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","article-title":"Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa","volume":"128","author":"Wong","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/mt.2015.58_bib36","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1038\/mt.2015.58_bib37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/sj.mt.6300041","article-title":"Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing","volume":"15","author":"Woodley","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2015.58_bib38","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fcell.2014.00050","article-title":"Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs)","volume":"2","author":"Pacini","year":"2014","journal-title":"Front Cell Dev Biol"},{"key":"10.1038\/mt.2015.58_bib39","doi-asserted-by":"crossref","first-page":"264ra165","DOI":"10.1126\/scitranslmed.3010083","article-title":"Genetically corrected iPSCs as cell therapy for recessive dystrophic epidermolysis bullosa","volume":"6","author":"Wenzel","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1038\/mt.2015.58_bib40","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1002\/stem.1806","article-title":"Are clinical trials with mesenchymal stem\/progenitor cells too far ahead of the science? Lessons from experimental hematology","volume":"32","author":"Prockop","year":"2014","journal-title":"Stem Cells"},{"key":"10.1038\/mt.2015.58_bib41","doi-asserted-by":"crossref","DOI":"10.1089\/scd.2014.0568","article-title":"Immunogenicity of Decidual Stromal Cells in an Epidermolysis Bullosa Patient and in Allogeneic Hematopoietic Stem Cell Transplantation Patients","author":"Kaipe","year":"2015","journal-title":"Stem Cells Dev"},{"key":"10.1038\/mt.2015.58_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nm.2574","article-title":"Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling","volume":"18","author":"Wong","year":"2012","journal-title":"Nat Med"},{"key":"10.1038\/mt.2015.58_bib43","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1365-2133.2009.09333.x","article-title":"Forty-two novel COL7A1 mutations and the role of a frequent single nucleotide polymorphism in the MMP1 promoter in modulation of disease severity in a large European dystrophic epidermolysis bullosa cohort","volume":"161","author":"Kern","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1038\/mt.2015.58_bib44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/pde.12146","article-title":"Cutaneous verrucous xanthoma in a bone marrow transplant recipient with recessive dystrophic epidermolysis bullosa","volume":"30","author":"Boyd","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1038\/mt.2015.58_bib45","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood-2008-06-161299","article-title":"Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells","volume":"113","author":"Tolar","year":"2009","journal-title":"Blood"},{"key":"10.1038\/mt.2015.58_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/scrt511","article-title":"Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa","volume":"5","author":"Perdoni","year":"2014","journal-title":"Stem Cell Res Ther"},{"key":"10.1038\/mt.2015.58_bib47","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1083\/jcb.131.2.551","article-title":"Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain","volume":"131","author":"Bruckner-Tuderman","year":"1995","journal-title":"J Cell Biol"},{"key":"10.1038\/mt.2015.58_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bcmd.2007.06.021","article-title":"Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation","volume":"40","author":"M\u00fcller","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1038\/mt.2015.58_bib49","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/14653240600920782","article-title":"Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM","volume":"8","author":"M\u00fcller","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1038\/mt.2015.58_bib50","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1128\/JVI.69.12.7430-7436.1995","article-title":"High-titer packaging cells producing recombinant retroviruses resistant to human serum","volume":"69","author":"Cosset","year":"1995","journal-title":"J Virol"},{"key":"10.1038\/mt.2015.58_bib51","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1089\/10430349950018157","article-title":"High-efficiency transduction and long-term gene expression with a murine stem cell retroviral vector encoding the green fluorescent protein in human marrow stromal cells","volume":"10","author":"Marx","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2015.58_bib52","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1182\/blood-2010-02-270777","article-title":"Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells","volume":"116","author":"Gieseke","year":"2010","journal-title":"Blood"},{"key":"10.1038\/mt.2015.58_bib53","doi-asserted-by":"crossref","first-page":"e64243","DOI":"10.1371\/journal.pone.0064243","article-title":"Rat model for dominant dystrophic epidermolysis bullosa: glycine substitution reduces collagen VII stability and shows gene-dosage effect","volume":"8","author":"Nystr\u00f6m","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/mt.2015.58_bib54","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1365-2133.1994.tb08546.x","article-title":"The epitope for anti-type VII collagen monoclonal antibody (LH7:2) locates at the central region of the N-terminal non-collagenous domain of type VII collagen","volume":"131","author":"Tanaka","year":"1994","journal-title":"Br J Dermatol"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616301721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T18:23:36Z","timestamp":1598898216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616301721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1525001616301721"],"URL":"https:\/\/doi.org\/10.1038\/mt.2015.58","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]}}}